MOLECULAR PARTNERS AG (MOLN) Social Stream
MOLECULAR PARTNERS AG (MOLN) Price Targets From Analysts
Use the tables below to see what analysts covering MOLECULAR PARTNERS AG think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-04 | 4 | $50 | $24 | $33.5 | $4.249 | 688.42% |
| 2022-01-14 | 4 | $50 | $24 | $35.25 | $4.249 | 729.61% |
| 2022-03-17 | 4 | $50 | $22 | $34.75 | $4.249 | 717.84% |
| 2022-04-28 | 4 | $50 | $22 | $31.5 | $4.249 | 641.35% |
| 2022-05-17 | 2 | $50 | $22 | $34 | $4.249 | 700.19% |
| 2022-08-29 | 2 | $22 | $8 | $15 | $4.249 | 253.02% |
| 2022-10-11 | 4 | $30 | $8 | $20 | $4.249 | 370.7% |
| 2022-11-23 | 4 | $30 | $6 | $14.666 | $4.249 | 245.16% |
| 2023-03-13 | 4 | $7 | $6 | $6.5 | $4.249 | 52.98% |
| 2023-06-02 | 4 | $30.001 | $6 | $14.333 | $4.249 | 237.33% |
| 2023-06-22 | 4 | $17 | $6 | $10 | $4.249 | 135.35% |
| 2023-07-07 | 4 | $15 | $6 | $9.333 | $4.249 | 119.65% |
| 2023-09-28 | 3 | $15 | $7 | $11 | $4.249 | 158.88% |
| 2023-12-05 | 3 | $15 | $4.5 | $8.833 | $4.249 | 107.88% |
The Trend in the Analyst Price Target
Over the past 25 months, MOLN's average price target has gone down $24.67.
MOLN reports an average of 90.31% for its upside potential over the past 38 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-13 | 4 | 30.000 | 6 | 14.333 | 6.45 | 122.22% |
| 2023-04-24 | 4 | 30.001 | 6 | 14.333 | 6.61 | 116.84% |
| 2023-06-02 | 4 | 30.001 | 6 | 14.333 | 6.60 | 117.17% |
| 2023-07-07 | 4 | 15.000 | 6 | 9.333 | 6.34 | 47.21% |
| 2023-09-28 | 3 | 15.000 | 7 | 11.000 | 4.17 | 163.79% |
MOLN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.33 | 1 | 0 | 2 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
MOLN's average broker recommendation rating improved by 0.17 over the prior 13 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MOLN as an investment opportunity.
- MOLECULAR PARTNERS AG's number of analysts covering the stock is greater than 205.71% of all US stocks.
- In the context of all US stocks, MOLECULAR PARTNERS AG's upside potential (average analyst target price relative to current price) is greater than 1876% of them.
- MOLECULAR PARTNERS AG's variance in analysts' estimates is lower than -1602.94% of all US stocks.
- In the context of stocks in the small market cap category, MOLECULAR PARTNERS AG's average analyst price target is higher than 1057.49% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to MOLECULAR PARTNERS AG are SOPH, CDXC, and AWH.
View All Top Stocks by Price Target
Is MOLN a Buy, Hold or Sell? See the POWR Ratings now!